N-Isopropyl-5-(pyridin-4-ylethynyl)picolinamide

Catalog No. :
ACLFDH627
CAS No. :
1401031-52-4
Molecular Formula :
C16H15N3O
Molecular Weight :
265.32

IUPAC Name:N-isopropyl-5-(pyridin-4-ylethynyl)picolinamide

N-Isopropyl-5-(pyridin-4-ylethynyl)picolinamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5mg98%$133.00Login to see priceInquiryInquiry
10mg98%$210.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameN-Isopropyl-5-(pyridin-4-ylethynyl)picolinamide
IUPAC NameN-isopropyl-5-(pyridin-4-ylethynyl)picolinamide
MDL No.MFCD23136020
Molecular FormulaC16H15N3O
Molecular Weight265.32
SMILESO=C(NC(C)C)C1=NC=C(C#CC2=CC=NC=C2)C=C1
InChI KeySTAFRSGTRKNXHF-UHFFFAOYSA-N
SynonymBGC03152 | GTPL6394 | 2-Pyridinecarboxamide, N-(1-methylethyl)-5-[2-(4-pyridinyl)ethynyl]- | CS-0033012 | N-Isopropyl-5-(pyridin-4-ylethynyl)picolinamide | 1401031-52-4 | HY-110152 | NCGC00370695-04 | LSN2463359 | LSN-2463359 | N-(propan-2-yl)-5-[2-(pyrid
CAS No.1401031-52-4
PubChem CID72551298

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACLFDH627 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACDHWR716 route compound structure diagram
    ACDHWR71629552-58-7 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACLFDH627 route product structure diagram
    ACLFDH6271401031-52-4
Inquiry

2. ACLFDH627 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACVURC286 route compound structure diagram
    ACVURC286352530-29-1 In Stock
  2. Plus
  3. ACILDP728 route compound structure diagram
    ACILDP728845305-90-0 In Stock
  4. Then
  5. ACLFDH627 route product structure diagram
    ACLFDH6271401031-52-4
Inquiry

Comments (0)